XSES
RCU
, Last price
SGD
Name
Revez Corporation Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Assurance Healthcare Limited, an investment holding company, operates in the healthcare business in Singapore. The company develops and distributes healthcare products and services and manages healthcare solutions through retail, direct selling, network marketing, and e-commerce. It offers managed healthcare solutions to corporations through a network of medical service providers to deliver healthcare services to the employees of corporations. It also offers various services, including real-time information and cost control; work injury case management; online employment medical check-up reports; and vaccination and infectious disease testing services. The company was formerly known as Revez Corporation Ltd. and changed its name to Assurance Healthcare Limited in August 2024. The company is based in Singapore.
Key people
Choon Hui Koh
Independent Chairman of the Board · since 2019
Wee Han Victor Neo
Chief Executive Officer, Deputy Executive Vice Chairman of the Board · since 2019
Mue Fun Yong
Group Financial Controller · since 2017
Han Chong Lee
Chief Creative Technology Officer, Executive Director · since 2019
Kian Sing Lim
Chief Operating Officer, Executive Director · since 2019
Choon Joo Sim
Executive Director, Group Project Director · since 2014
Yoen Har Wong
Secretary · since 2017
Non-Executive Director · since 2019
Choon Noi Lim
Independent Director · since 2019
Legal address
29 MEDIA CIRCLE, #03-13, ALICE@MEDIAPOLIS
SINGAPORE, 05 138565
SG
SINGAPORE, 05 138565
SG
Headquarters
29 MEDIA CIRCLE, ALICE@MEDIAPOLIS,
SOUTH TOWER #03-13,
SINGAPORE, 05 138565
SG
SOUTH TOWER #03-13,
SINGAPORE, 05 138565
SG
Previous name
JASON PARQUET HOLDINGS PTE. LTD.
Previous name
JASON HOLDINGS LIMITED
Previous name
JASON PARQUET HOLDINGS LIMITED
Valuation
Title SGD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||